Physical Activity in Persons With Parkinson's Disease

NCT07585409 — Recruiting, 450 participants, Karolinska Institutet

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Physical Activity in Persons With Parkinson's Disease - a Longitudinal Cohort Study

RegistryNCT07585409, acronym ActivPARK
StatusRecruiting
Study typeObservational
Enrollment450 (Estimated)
SponsorKarolinska Institutet (Other); collaborators: Lund University, Göteborg University, Umeå University, Region Stockholm, Vastra Gotaland Region, Region Skane, Region Västerbotten, Region Norrbotten
ConditionsPARKINSON DISEASE (Disorder), Physical Activity, Sedentary Behaviors
Datesstart 2026-01-15, primary completion 2030-12-31 (estimated), completion 2031-01-30 (estimated), first posted 2026-05-13, last updated 2026-05-15
Locations1 site in Sweden

Related Papers Related Patents Related Grants Related Experts
All trials for PARKINSON DISEASE (Disorder) All trials for Physical Activity

-Summary

This project aims to identify why some people with Parkinson's disease (PwPD) become less physically active, and which factors support or hinder activity. Understanding these factors is essential for developing person centred interventions and effective support that can be implemented in routine healthcare. A national, multicentre longitudinal cohort study will be conducted including approx 450 PwPD from five Swedish regions (including the internal pilot NCT06901869). Physical activity will be measured objectively with activity monitors, combined with clinical assessments and digital questionnaires over four years. The primary outcome is physical activity level (accelerometer measured decline), and exposure variables include physical, cognitive, disease specific, social, environmental, motivational, and personal factors. Data collection involves clinical tests, questionnaires, accelerometer data, and patient reported experiences.

This is a continuation of an internal pilot study NCT06901869. The study will enable early identification of those at risk for declining activity and guide development of person centred, evidence based interventions. Long term, it aims to integrate activity monitoring and risk factor screening into routine care to improve health and quality of life for PwPD.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
People with Parkinson´'s diseaseNo intervention

+Outcome measures

Primary outcomes

  • Physical activity - low and moderate intensity [Baseline and yearly follow-ups for 3 years]: The primary outcome is changes over time in PA (i.e. low + moderate-vigorous intensity PA in time spent per day) measured with accelerometers (Actigraph GT3X+, Pensacola, FL, US) during 7 days in people with Parkinson's disease everyday life.

Secondary outcomes

  • Physical activity - total vector magnitude [Baseline and yearly follow-ups for 3 years]: The secondary outcomes are change over time in total vector magnitude measured with accelerometers (Actigraph GT3X+, Pensacola, FL, US) during 7 days in people with Parkinson's disease everyday life.
  • Physical activity - low intensity [Baseline and yearly follow-ups for 3 years]: The secondary outcomes are change in time spent in low intensity physical activity per day measured with accelerometers (Actigraph GT3X+, Pensacola, FL, US) during 7 days in people with Parkinson's disease everyday life.
  • Physical activity - moderate high intensity [Baseline and yearly follow-ups for 3 years]: The secondary outcomes are change in time spent in moderate-vigorous physical activity per day measured with accelerometers (Actigraph GT3X+, Pensacola, FL, US) during 7 days in people with Parkinson's disease everyday life.
  • Physical activity- sedentary [Baseline and yearly follow-ups for 3 years]: The secondary outcomes are change in sedentary time per day measured with accelerometers (Actigraph GT3X+, Pensacola, FL, US) during 7 days in people with Parkinson's disease everyday life.
  • Physical activity - steps [Baseline and yearly follow-ups for 3 years]: The secondary outcomes are change in steps per day measured with accelerometers (Actigraph GT3X+, Pensacola, FL, US) during 7 days in people with Parkinson's disease everyday life.

Other outcomes

  • Disease severity, Parkinsons symptoms [Baseline and 3 year follow-up]: Disease severity measured with the Movement Disorders Society -Unified Parkinson's Disease Rating Scale) parts 1 to 4. Higher scores = worse/more symptoms
  • Gait [Baseline and 3 year follow-up]: Gait speed in m/s measured with the 10 meter walking test or through gait analysis.
  • Balance performance [Baseline and 3 year follow-up]: Assessed with the Mini-BESTest. Mini-Balance Evaluation Systems Test a rating scale for dynamic balance incorporating 14 different balance and gait items that were assessed by a physical therapist on a scale from 0-2. 0-28 points with higher scores indicating better balance control
  • Anxiety and depression [Baseline and yearly follow-ups for 3 years]: Assessed with Hospital Anxiety and Depression Scale (HADS), 0-24 on the depression and anxiety part respectively. Lower score=better
  • Cognitive performance [Baseline and 3 year follow-up]: Assessed with the Montreal Cognitive Assessment (MoCA), 0-25, higher score = better
  • Motivation [Baseline and yearly follow-ups for 3 years]: Assessed with the Behavioural Regulation in Exercise Questionnaire (BREQ 4), a 28-item survey that measures exercise motivation. The questionnaire uses a 7-point Likert scale, ranging from one to seven. Maximum 196. Higher scores = higher motivation
  • Self-efficacy [Baseline and yearly follow-ups for 3 years]: Assessed with the Self-efficacy and motivation for exercise/physical activity (ESES). 10 questions rated on a 4 point Likert scale. Maximun 40 points, higher scores= better self-efficacy
  • Physical activity history and preferences, [Baseline]: Self-made questions on physical activity history and preferences
  • Self assessed cognitive function [Baseline and yearly follow-ups for 3 years]: Assessed with Executive function questionnaire (DEX), 20 items scored 1 to 4, max 80, more scores= worse
  • Non-Motor Symptoms [Baseline and yearly follow-ups for 3 years]: Non-Motor Symptoms Questionnaire (NMSQ), 30 questions with yes/no answer. More yes answers = more non-motor symptoms
  • Walking ability- self rated [Baseline and yearly follow-ups for 3 years]: WALK-12G questionnaire, 0 and 42 points, with higher scores reflecting greater perceived walking difficulties (higher=worse)
  • Freezing of gait - self-assessed [Baseline and 3 year follow-up]: Freezing of gait questionnaire (FOGQsa), 6 questions/items, scored 1 to 5 (higher=worse)
  • Balance confidence [Baseline and yearly follow-ups for 3 years]: Activities specific balance confidence (ABC scale), 16 items which is scored 1 to 10 and then divided by 16. 0-100%, higher % = better
  • Fatigue [Baseline and yearly follow-ups for 3 years]: Parkinson's Fatigue Scale (PFS-16), 16 items scored 1 to 5 from strongly disagree to strongly agree . more points/score= worse.
  • Disability [Baseline and 3 year follow-up]: World health organization (WHO) disability assessment schedule (Whodas 2.0), 12 self-assessed questions (12 to 60) more points=worse
  • Sleep [Baseline and 3 year follow-up]: Scales for Outcomes in Parkinson's disease - Sleep (SCOPA-SLEEP), 4 parts, A-2 questions, B-5 questions , C-1 question and D- 6 questions. Higher= worse
  • Self-rated pain [Baseline and yearly follow-ups for 3 years]: Assessed with visual analog scale, VAS from 0 to 100
  • Health related quality of life [Baseline and yearly follow-ups for 3 years]: Parkinson's Disease Questionnaire (PDQ39). The Parkinson's Disease Questionnaire (PDQ-39) assesses how often people with Parkinson's experience difficulties across 8 dimensions of daily living (mobility, activities of daily living, emotional well-being, stigma, social support, cognition, communications and bodily discomfort). The sum score is as a percentage score ranging between 0 and 100. Higher is better
  • Wellbeing [Baseline and yearly follow-ups for 3 years]: The WHO- Five Well-Being Index (WHO-5), 5 questions ranging from 0 to 5, 0-25, higher=better
  • Nutrition [Baseline and 3 year follow-up]: Mini Nutritional Assessment, max 14. higher = better
  • Socioeconomic status [Baseline]: Education and income level.

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* People diagnosed with idiopathic Parkinson's disease
* Hoehn \& Yahr 1 to 4

Exclusion Criteria:

* Hoehn \& Yahr 5 (i.e. wheelchair bound or bedridden unless aided)
* Unable to perform critical physical activity and clinical assessments

+Locations (1)

FacilityCityCountryStatus
Karolinska University HospitalStockholmSwedenRecruiting

+Investigators

  • Erika Franzén, Principal investigator, Karolinska Institutet